documents: FDA-1978-N-0018-0826
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1978-N-0018-0826 | FDA | FDA-1978-N-0018 | Letter from King & Spalding on behalf of Givaudan-Roure Corporation to FDA/CDER | Other | Letter(s) | 2018-04-05T04:00:00Z | 2018 | 4 | 2018-04-05T04:00:00Z | 2019-07-23T16:56:06Z | 0 | 0 | 090000648055a05c |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref